A phase 1 randomized controlled trial of a peptide-based group A streptococcal vaccine in healthy volunteers
Vanessa Meier‐Stephenson(University of Alberta), Maryna Yaskina(University of Alberta), Ailin Lepletier(Griffith University), Simone Reynolds(Griffith University), Chris Davis(Fred Hutch Cancer Center), Ainslie Calcutt(Griffith University), Catherine Burton, Michael F. Good(Griffith University), Michael Hawkes(University of British Columbia), Gregory J. Tyrrell(University of Alberta), Jessica Dooley(Griffith University), Manisha Pandey(Griffith University), Eloise C. Keeffe(Griffith University), Victoria Ozberk(Griffith University), D. Lorne Tyrrell(University of Alberta), Conar O’Neil(University of Alberta), Alena Tse‐Chang(University of Alberta), Ijeoma Ogbuehi(University of Alberta), Michael Houghton(University of Alberta), William Stokes(Emory University), Kelly Kim(University of Alberta), B. Tyrrell(University of Alberta)
Cited by 12
Related Papers
Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B Hepatitis
|New England Journal of Medicine|1989|1.7k
A proposed system for the nomenclature of hepatitis C viral genotypes
|Hepatology|1994|1k
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
|Journal of Clinical Investigation|1996|661
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
|Cancer Discovery|2019|272